Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) ...

Twenty years after publication of the report To Err Is Human, studies demonstrate persisting high levels of patient harm. Most patient safety measurement remains highly retrospective, relying on ...

C21 Subscription and C21Insight subscribers. You can access this subscription story - and hundreds more like them every month - for as little as £17/month. This premium content is only accessible with ...

Inverse optimisation and linear programming have emerged as crucial instruments in addressing complex decision-making problems where underlying models must be inferred from observed behaviour. At its ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Cassidy Horton is a finance writer covering banking, life insurance and business loans. She has worked with top finance brands including NerdWallet, MarketWatch and Consumer Affairs. Cassidy first ...

ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...

Cisplatin remains a cornerstone in oncological treatment, yet its use is often limited by ototoxicity—a side effect that causes irreversible sensorineural hearing loss. This adverse effect ...